Mechanisms and Innovations in Cardiac Resynchronisation Therapy

  • STATUS
    Recruiting
  • participants needed
    60
  • sponsor
    Imperial College London
Updated on 16 February 2024
cardiac resynchronization therapy
atrio-biventricular pacing
biventricular pacing

Summary

The aim of this study is to compare the effectiveness of multiple modalities of cardiac resynchronisation therapy using high precision acute electrical and haemodynamic measurements.These modalities include biventricular pacing and conduction system pacing utilising His bundle and left bundle pacing. Conduction system pacing is a more physiological form of pacing. We hypothesise that this will produce more effective cardiac resynchronisation.

Description

This is a single centre acute electrical/haemodynamic and observational study of a subgroup of patients with heart failure. A total of 60 will be recruited. The acute study involves within patient comparison of biventricular and conduction system pacing using detailed electrical mapping and high precision haemodynamic measurement protocol.

Participants will have permanent conduction system pacing if;

  • Baseline left bundle branch block and QRS > 140ms or QRS >150ms and any QRS morphology AND
  • Conduction system pacing is successful at reducing QRS duration by 20ms or more with satisfactory pacing parameters.

Participants who receive permanent conduction system pacing will have follow up at 6 weeks, 3 months, 6 months and 12 months. Non-invasive markers including mechanical activation pattern (echocardiography and cardiac MRI) and electrical activation pattern (ultra-high frequency electrocardiography) will be used to identify the characteristics of patients who benefit from conduction system pacing.

Details
Condition Right bundle branch block, Heart failure, Heart failure, Heart disease, Heart disease, Left Ventricular Systolic Dysfunction, Non-Specific Intraventricular Conduction Defect
Age 18years - 100years
Treatment His-bundle pacing.
Clinical Study IdentifierNCT04221763
SponsorImperial College London
Last Modified on16 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients referred for conventional CRT
Severe heart failure (LVEF, a measure of heart pumping, < 35% - severe)
Prolonged QRS duration (>120ms)
Adults willing to take part (age > 18 years)
Able to give consent

Exclusion Criteria

Unable to give consent
Children (age < 18 years)
Pregnant women
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.